Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 76 - 100 of 9760 in total
Efanesoctocog alfa (BIVV001) is a recombinant factor VIII (FVIII) analogue fusion protein used for the routine prophylaxis, perioperative management of bleeding and on-demand treatment and control of bleeding episodes in patients with hemophilia A. The use of FVIII replacement products is beneficial in patients with hemophilia A; however, their quality...
Approved
Investigational
Matched Synonyms: … Antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl …
Matched Description: … Efanesoctocog alfa (BIVV001) is a recombinant factor VIII (FVIII) analogue fusion protein used for the …
Matched Categories: … Recombinant Fusion Proteins …
Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) is a vaccine that contains inactivated acellular pertussis antigen that is isolated from Bordetella pertussis culture.
Approved
Investigational
Matched Name: … Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) …
Matched Description: … inactivated acellular pertussis antigen that is isolated from Bordetella pertussis culture. ... Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) is a vaccine that contains …
Matched Mixtures name: … ANTIGEN, and BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN ... CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN ... (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED), BORDETELLA …
Streptococcus pneumoniae type 6b capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 6b of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
Approved
Investigational
Matched Name: … Streptococcus pneumoniae type 6b capsular polysaccharide antigen
Matched Description: … Streptococcus pneumoniae type 6b capsular polysaccharide antigen is a vaccine that contains highly purified …
Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) is a vaccine that is used in the prophylaxis of Pertussis (whooping cough), which is caused by a small Gram-negative coccobacillus that infects the mucosal layers of the human respiratory tract.
Approved
Matched Name: … Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) …
Matched Description: … Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) is a vaccine that is used …
Streptococcus pneumoniae type 2 capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 2 of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
Approved
Investigational
Matched Name: … Streptococcus pneumoniae type 2 capsular polysaccharide antigen
Matched Description: … Streptococcus pneumoniae type 2 capsular polysaccharide antigen is a vaccine that contains highly purified …
Streptococcus pneumoniae type 7f capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 7f of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
Approved
Investigational
Matched Name: … Streptococcus pneumoniae type 7f capsular polysaccharide antigen
Matched Description: … Streptococcus pneumoniae type 7f capsular polysaccharide antigen is a vaccine that contains highly purified …
Streptococcus pneumoniae type 9v capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 9v of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
Approved
Investigational
Matched Name: … Streptococcus pneumoniae type 9v capsular polysaccharide antigen
Matched Description: … Streptococcus pneumoniae type 9v capsular polysaccharide antigen is a vaccine that contains highly purified …
Streptococcus pneumoniae type 20 capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 20 of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
Approved
Investigational
Matched Name: … Streptococcus pneumoniae type 20 capsular polysaccharide antigen
Matched Description: … Streptococcus pneumoniae type 20 capsular polysaccharide antigen is a vaccine that contains highly purified …
Streptococcus pneumoniae type 10a capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 10a of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
Approved
Investigational
Matched Name: … Streptococcus pneumoniae type 10a capsular polysaccharide antigen
Matched Description: … Streptococcus pneumoniae type 10a capsular polysaccharide antigen is a vaccine that contains highly purified …
Streptococcus pneumoniae type 33f capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 33f of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
Approved
Investigational
Matched Name: … Streptococcus pneumoniae type 33f capsular polysaccharide antigen
Matched Description: … Streptococcus pneumoniae type 33f capsular polysaccharide antigen is a vaccine that contains highly purified …
Somatrogon is a long-acting recombinant human growth hormone. Growth hormone is a peptide hormone secreted by the pituitary gland that plays a crucial role in promoting longitudinal growth during childhood and adolescence and regulating metabolic function in adulthood. Recombinant growth hormone therapy for growth hormone deficiency and other conditions has...
Approved
Matched Synonyms: … CTP-SOMATROPIN FUSION PROTEIN ... -SUBUNIT) FUSION PROTEIN WITH SOMATOTROPIN (HUMAN) FUSION PROTEIN WITH 118-145-CHORIONIC GONADOTROPIN ... SOMATROPIN-CTP FUSION PROTEIN
Matched Description: … [A241515,L39362] The glycosylation and the presence of CTPs in the protein sequence prolongs the half-life …
Talquetamab is a IgG4-PAA bispecific G protein-coupled receptor class C group 5 member D (GPRC5D)-directed CD3 T-cell engager. It consists of two arms - anti-GPRC5D and anti-CD3 arms - linked by two interchain disulfide bonds, each arm comprising a heavy and light chain. Talquetamab binds to GPRC5D, a cell surface...
Approved
Investigational
Matched Synonyms: … IMMUNOGLOBULIN G4-KAPPA/G4-LAMBDA, ANTI-(HOMO SAPIENS GPRC5D (G PROTEIN-COUPLED RECEPTOR CLASS C GROUP ... IMMUNOGLOBULIN G4-KAPPA/G4-LAMBDA, ANTI-(HOMO SAPIENS GPRC5D (G PROTEIN-COUPLED RECEPTOR CLASS C GROUP ... IMMUNOGLOBULIN G4 (233-PROLINE,239-ALANINE,240-ALANINE,410-LEUCINE,414-LYSINE), ANTI-(HUMAN CD3 ANTIGEN
Matched Description: … Talquetamab is a IgG4-PAA bispecific G protein-coupled receptor class C group 5 member D (GPRC5D)-directed …
Tagraxofusp is a CD123-directed cytotoxin. It is a fusion protein composed of a human interleukin-3 (IL-3) that is genetically fused to the catalytic and translocation domains of truncated diphtheria toxin (DT) produced in Escherichia coli.[A253762, A253887, L43702] Tagraxofusp received its first global approval by the FDA on December 21, 2018...
Approved
Investigational
Matched Synonyms: … Diphtheria toxin-il-3 fusion protein targeting IL-3 receptor …
Matched Description: … It is a fusion protein composed of a human interleukin-3 (IL-3) that is genetically fused to the catalytic …
Matched Categories: … Recombinant Fusion Proteins …
Approved
Matched Name: … Cyd dengue virus serotype 4 live (attenuated) antigen
Arexvy (respiratory syncytial virus vaccine, adjuvanted) is an adjuvanted vaccine developed by GlaxoSmithKline Biologicals. It comprises lyophilized recombinant respiratory syncytial virus glycoprotein F (RSVPreF3) stabilized in pre-fusion conformation as the antigen component, which is reconstituted at the time of use with the accompanying vial of AS01E adjuvant as the adjuvant...
Approved
Matched Synonyms: … RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS PRE-FUSION F PROTEIN ... RESPIRATORY SYNCYTIAL VIRUS PREFUSION F PROTEIN (RSVPREF3) …
Matched Description: … conformation as the antigen component, which is reconstituted at the time of use with the accompanying ... comprises lyophilized recombinant respiratory syncytial virus glycoprotein F (RSVPreF3) stabilized in pre-fusion
A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence...
Approved
Matched Synonyms: … Influenza Virus Vaccine, Inactivated A-Christchurch-16-2010 NIB-74 (H1N1) (A-California-7-2009) strain
Matched Name: … Influenza A virus A/Christchurch/16/2010 NIB-74 (H1N1) antigen (propiolactone inactivated) …
Matched Description: … defence includes the production of humoral immunity through the development of antibodies (through memory B ... parts of the virus) which stimulates an immunological defence against future exposure to the virus, or "antigen
A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence...
Approved
Matched Name: … Influenza A virus A/Brisbane/10/2010 live (attenuated) antigen
Matched Description: … defence includes the production of humoral immunity through the development of antibodies (through memory B ... parts of the virus) which stimulates an immunological defence against future exposure to the virus, or "antigen
Typhoid Vi polysaccharide vaccine is a vaccine that is administered intramuscularly. It is an active immunization for the prevention of typhoid fever caused by S typhi and is approved for use in persons two years of age or older. The vaccine contains the purified cell surface Vi polysaccharide extracted from...
Approved
Matched Synonyms: … Salmonella typhi TY2 Vi polysaccharide antigen ... Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain
Matched Description: … purified cell surface Vi polysaccharide extracted from *Salmonella enterica* serovar *Typhi, S typhi Ty2* strain
Matched Categories: … typhoid, purified polysaccharide antigen
Etodolac is a non-steroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic and antipyretic properties. Its therapeutic effects are due to its ability to inhibit prostaglandin synthesis. It is indicated for relief of signs and symptoms of rheumatoid arthritis and osteoarthritis.
Approved
Investigational
Vet approved
Matched Synonyms: … (±)-1,8-diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid ... 1,3,4,9-tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid ... 1,8-diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid …
Matched Iupac: … 2-{1,8-diethyl-1H,3H,4H,9H-pyrano[3,4-b]indol-1-yl}acetic acid …
A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence...
Approved
Matched Name: … Influenza A virus A/Hawaii/66/2019 (H1N1) live (attenuated) antigen
Matched Description: … defence includes the production of humoral immunity through the development of antibodies (through memory B ... parts of the virus) which stimulates an immunological defence against future exposure to the virus, or "antigen
A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence...
Approved
Matched Name: … Influenza A virus A/South Australia/55/2014 live (attenuated) antigen
Matched Description: … defence includes the production of humoral immunity through the development of antibodies (through memory B ... parts of the virus) which stimulates an immunological defence against future exposure to the virus, or "antigen
A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence...
Approved
Matched Name: … Influenza A virus A/Slovenia/2903/2015 (H1N1) live (attenuated) antigen
Matched Description: … defence includes the production of humoral immunity through the development of antibodies (through memory B ... parts of the virus) which stimulates an immunological defence against future exposure to the virus, or "antigen
A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence...
Approved
Matched Name: … Influenza A virus A/Michigan/45/2015 (H1N1) recombinant hemagglutinin antigen
Matched Description: … defence includes the production of humoral immunity through the development of antibodies (through memory B ... parts of the virus) which stimulates an immunological defence against future exposure to the virus, or "antigen
A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence...
Approved
Matched Name: … Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated) …
Matched Description: … defence includes the production of humoral immunity through the development of antibodies (through memory B ... parts of the virus) which stimulates an immunological defence against future exposure to the virus, or "antigen
A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence...
Approved
Matched Name: … Influenza A virus A/Kansas/14/2017 (H3N2) recombinant hemagglutinin antigen
Matched Description: … defence includes the production of humoral immunity through the development of antibodies (through memory B ... parts of the virus) which stimulates an immunological defence against future exposure to the virus, or "antigen
Displaying drugs 76 - 100 of 9760 in total